America's Health Insurance Plans, the primary lobbyist for the health insurance industry, is funding a “seven-figure” ad campaign that targets Medicare Advantage and aims to put pressure on the Obama administration to stabilize funding for the private version of Medicare.
Former CMS chief Marilyn Tavenner discusses her move to head up America's Health Insurance Plans and the challenges faced by the group's members, which have struggled in the fledgling insurance marketplaces created under the ACA.
The CMS’ previous administrator, Marilyn Tavenner, criticized the agency after an analysis showed it has underpaid Medicare Advantage plans for the costs of treating individuals with chronic conditions.
Podcast Q&A: Exchange strategy seeks 'getting the right steps in place to ensure long-term stability,' Tavenner says
In a podcast interview, former CMS chief Marilyn Tavenner discusses her move to head up America's Health Insurance Plans, the industry's leading advocacy group. She also addresses the challenges faced by the group's members, which have struggled in the fledgling insurance marketplaces created under...
Former CMS Administrator Marilyn Tavenner is criticizing the agency after a new analysis shows it is underpaying Medicare Advantage plans for the costs of treating individuals with multiple chronic conditions.
Big insurance mergers, the evolution of the nation's delivery systems, the direction of drug and device regulation—these are some of the more important issues we'll be covering this year, and they drove our decisions on which people to watch in 2016.
Aetna's departure from AHIP months after UnitedHealth Group bolted is further evidence that the large national insurers are increasingly happy to fight their own battles on Capitol Hill, such as shepherding their pending mega-mergers and negotiating changes to the ACA marketplaces.
Another top-five health insurance company is ditching the industry lobbying group as a new CEO attempts to right the ship.
High prescription drug prices will be a top-tier political issue in 2016 as the expected introduction of many expensive specialty medications to treat chronic conditions threatens to drive up healthcare spending.
Dr. John Bennett, president and CEO of Capital District Physicians' Health Plan, has emerged as one of the more outspoken board members of America's Health Insurance Plans. He says the public shouldn't think of Martin Shkreli and Turing Pharmaceuticals as an isolated case.
It was as a son, not a healthcare CEO, that I experienced the pain of my mom's “do not resuscitate” order being ignored. Her medical team pushed through the door and subjected her to a full code, against her wishes, the night her heart beat for the last time.
Dr. Michael Cropp, president and CEO of Independent Health, a not-for-profit health insurer based in Buffalo, N.Y., discusses surprise medical bills, how his plan reduced premiums this year and his views of prescription drug prices. He spoke with Modern Healthcare reporter Bob Herman.